logo
logo

Podimetrics Secures $45 Million Series C To Help At-Risk Providers And Health Plans Prevent Diabetic Amputations In High-Risk Patients

Podimetrics Secures $45 Million Series C To Help At-Risk Providers And Health Plans Prevent Diabetic Amputations In High-Risk Patients

03/24/22, 8:00 AM
Location
https://purecatamphetamine.github.io/country-flag-icons/3x2/US.svgsomerville
Money raised
$45 million
Round Type
series c
Podimetrics, creator of the FDA-cleared SmartMatTM and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced a $45 million Series C round led by D1 Capital Partners, along with two new investors, the Medtech Convergence Fund and an undisclosed strategic investor. Existing investors, Polaris Partners and Scientific Health Development, also participated in the financing. Prior to their Series C, Podimetrics had raised $28.3 million in funding to fuel development and distribution of their SmartMat.

Company Info

Company
Podimetrics
Location
somerville, pennsylvania, united states
Additional Info
Podimetrics is the creator of the FDA-cleared SmartMatTM and integrated clinical care services that can help save the limbs and lives of complex diabetic patients. Through partnerships with regional and national health plans and at-risk providers, such as the Veterans Health Administration, Podimetrics has helped prevent amputations associated with complex diabetes. By combining cutting-edge technology with best-in-class clinical care services, Podimetrics earns high engagement rates from patients and allows clinicians to save limbs, lives, and money — all while keeping vulnerable populations healthy in their own homes. For more information, visit podimetrics.com or follow us on LinkedIn and Twitter.